|Day's Range||3.5500 - 3.7000|
By Liz Moyer
The mean of analysts' price targets for Pacific Biosciences (PACB) points to a 30.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Key Insights Using the 2 Stage Free Cash Flow to Equity, Pacific Biosciences of California fair value estimate is...